Skip to main content

Table 3 Prevalence of RTOG grade 2 or higher genitourinary or gastrointestinal toxicity

From: Favorable outcomes in locally advanced and node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy

 

RTOG Grade 2 toxicity

RTOG Grade 3 toxicity

GU-tract, N (%)

  

 Hematuria

2 (1)

1 (<1)

 Urinary retention

6 (4)

2 (1)

 Urinary frequency

49 (36)

14 (10)

 Dysuria

5 (4)

2 (1)

 Urinary urgency

63 (46)

15 (11)

 Urinary leakage

5 (4)

1 (<1)

GI-tract, N (%)

  

 Fecal urgency

37 (27)

2 (1)

 Blood in stool

17 (13)

0 (0)

 Loose stools

10 (7)

1 (<1)

 Fecal incontinence

10 (7)

1 (<1)

  1. Abbreviations: Genitourinary (GU), Gastrointestinal (GI)